Loading
institutionsInstitution
Department of Biotechnology, Government of India
The government department that funds India's life-science institutes and, through BIRAC, the start-ups behind the country's indigenous CAR-T therapies and HPV vaccine.
Also called: DBTBIRACBiotechnology Industry Research Assistance Council
Overview
The Department of Biotechnology was created in 1986 under the Ministry of Science and Technology. It runs autonomous institutes including the National Institute of Immunology (Delhi), the National Centre for Cell Science (Pune), the Institute for Stem Cell Science and Regenerative Medicine (Bengaluru), the Translational Health Science and Technology Institute (Faridabad), the Rajiv Gandhi Centre for Biotechnology (Thiruvananthapuram) and the Institute of Life Sciences (Bhubaneswar), and funds industry through the Biotechnology Industry Research Assistance Council (BIRAC), a public sector undertaking that supports biotech commercialisation.
For cancer, DBT and BIRAC grants sit behind much of the indigenous pipeline: the IIT Bombay and Tata Memorial CAR-T programme that became NexCAR19, academic cell therapy and gene therapy at inStem and CMC Vellore, and the development and rollout of the Serum Institute's quadrivalent HPV vaccine.
Location
New Delhi, IN
Type
government
Archived website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#292 · 22 points (0 Newsweek + 0 NCI + 22 from 11 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-01.
Matched to Government of India, including child institutions. 1,631 works · 13,198 citations · 60% open access · 5% clinical trials · 2% reviews.
Oncology works per year
3482022
3062023
3442024
3422025
2912026
Most works
- Ajay Gogia55 works
- Atul Batra39 works
- Chandra Prakash Prasad28 works
- Rachna Kapoor Seth26 works
- Sameer Rastogi26 works
- Sunil Martin26 works
- Raja Pramanik24 works
- Sandip Kanti Basu24 works
- Prabhat Singh Malik21 works
- Sandeep Rajinder Mathur19 works
Most cited
- Autonomous life-science institutes
- BIRAC start-up and translational grants
- Cell and gene therapy programmes
- Vaccine development support
Similar pages
- PersonRahul Purwar
Shares Indian Institute of Technology Bombay, Point-of-care and decentralised cell manufacturing, ImmunoACT, Manufacturing cost and time for living and radioactive medicines.
- TrialTalicabtagene autoleucel (NexCAR19) phase 1/2
Shares Indian Institute of Technology Bombay, Point-of-care and decentralised cell manufacturing, ImmunoACT, Manufacturing cost and time for living and radioactive medicines.
- Key paperTalicabtagene autoleucel for relapsed or refractory B-cell malignancies: an open-label, multicentre, phase 1/2 study
Shares Indian Institute of Technology Bombay, ImmunoACT, Manufacturing cost and time for living and radioactive medicines, CAR-T cell therapy.
- TreatmentTalicabtagene autoleucel
Shares Indian Institute of Technology Bombay, Point-of-care and decentralised cell manufacturing, ImmunoACT, Manufacturing cost and time for living and radioactive medicines.
- InstitutionAdvanced Centre for Treatment, Research and Education in Cancer
Shares Indian Institute of Technology Bombay, Point-of-care and decentralised cell manufacturing, ImmunoACT, CAR-T cell therapy.
- IdeaPublic cell-therapy foundries at cancer centres for academics and start-ups
Shares The valley of death between lab and product, Manufacturing cost and time for living and radioactive medicines, CAR-T cell therapy.
- CompanyImmuneel Therapeutics
Shares Point-of-care and decentralised cell manufacturing, Manufacturing cost and time for living and radioactive medicines, CAR-T cell therapy.
- TrialIMAGINE (varnimcabtagene autoleucel, Immuneel)
Shares Point-of-care and decentralised cell manufacturing, Manufacturing cost and time for living and radioactive medicines, CAR-T cell therapy.
fronts
technologies
drugs
ApprovedProphylactic vaccine (virus-like particles)
CERVAVAC (quadrivalent HPV vaccine, India) · CERVAVAC